Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.18)
# 4,743
Out of 5,136 analysts
125
Total ratings
39.8%
Success rate
-10.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterated: Buy | $140 | $60.57 | +131.14% | 2 | Nov 5, 2026 | |
| ZLAB Zai Lab | Reiterated: Buy | $37 | $23.47 | +57.65% | 10 | Oct 25, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $300 | $271.73 | +10.40% | 27 | Sep 25, 2026 | |
| NUVB Nuvation Bio | Initiated Coverage: Buy | $12 | $3.84 | +212.50% | 1 | Aug 21, 2026 | |
| REPL Replimune Group | Upgraded: Buy | n/a | $21.41 | - | 6 | Jul 31, 2026 | |
| ANL Adlai Nortye Group | Reiterated: Buy | n/a | $10.03 | - | 2 | Jul 16, 2026 | |
| IMRX Immuneering | Initiated Coverage: Buy | $17 | $3.52 | +382.95% | 1 | Jul 8, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | n/a | $9.28 | - | 2 | Jun 3, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $0.4358 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $19.74 | - | 2 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.56 | - | 1 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.6615 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.86 | n/a | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.1659 | n/a | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.77 | n/a | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.36 | n/a | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.09 | n/a | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.60 | n/a | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.46 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.38 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.00 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.18 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.66 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.14 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.015 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $38 | $1.21 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $7.47 | n/a | 3 | Jun 28, 2022 |
Celcuity
Nov 5, 2026
Reiterated: Buy
Price Target: $140
Current: $60.57
Upside: +131.14%
Zai Lab
Oct 25, 2026
Reiterated: Buy
Price Target: $37
Current: $23.47
Upside: +57.65%
Ascendis Pharma
Sep 25, 2026
Reiterated: Buy
Price Target: $300
Current: $271.73
Upside: +10.40%
Nuvation Bio
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.84
Upside: +212.50%
Replimune Group
Jul 31, 2026
Upgraded: Buy
Price Target: n/a
Current: $21.41
Upside: -
Adlai Nortye Group
Jul 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.03
Upside: -
Immuneering
Jul 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $3.52
Upside: +382.95%
Faeth Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.28
Upside: -
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $0.4358
Upside: -
Tyra Biosciences
Mar 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.74
Upside: -
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $11.56
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.6615
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.86
Upside: n/a
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.1659
Upside: n/a
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $6.77
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $30.36
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.09
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $10.60
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.46
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.38
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.00
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $3.18
Upside: n/a
Aug 30, 2023
Reiterated: Buy
Price Target: $11
Current: $2.66
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $1.14
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.015
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $71 → $38
Current: $1.21
Upside: n/a
Jun 28, 2022
Reiterated: Buy
Price Target: $16 → $6
Current: $7.47
Upside: n/a